vTv Therapeutics (VTVT) SEC Filings & 10K Form $13.53 -1.53 (-10.16%) Closing price 07/3/2025 02:15 PM EasternExtended Trading$14.07 +0.54 (+3.98%) As of 07/3/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent vTv Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView05/21/20255:16 PMTung Michael Stephen (Reporting)vTv Therapeutics (Issuer)Form 3Initial statement of beneficial ownership of securities 05/21/20255:17 PMTung Michael Stephen (Reporting)vTv Therapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/19/20253:24 PMvTv Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/16/20258:05 AMvTv Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/15/20253:07 PMvTv Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/01/20253:28 PMTuch Steven L. (Reporting)vTv Therapeutics (Subject)Form 144Notice of proposed sale of securities pursuant to Rule 144 04/24/20253:40 PMAKKARAJU SRINIVAS (Reporting)vTv Therapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 03/20/20253:27 PMvTv Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/20/20253:28 PMvTv Therapeutics (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/17/20258:03 AMvTv Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/27/20253:14 PMvTv Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/13/20257:33 AMvTv Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/06/20243:15 PMAKKARAJU SRINIVAS (Reporting)vTv Therapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 12/06/20243:15 PMSamsara BioCapital GP, LLC (Reporting)Samsara BioCapital, L.P. (Reporting)vTv Therapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 11/12/20249:40 AMFMR LLC (Filed by)vTv Therapeutics (Subject)Form SC 13G10/25/20243:29 PMvTv Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/23/20243:28 PMvTv Therapeutics (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 08/08/20243:27 PMvTv Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/26/20243:17 PMvTv Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies CytomX Therapeutics 10Q Form Organigram Global 10Q Form GENFIT 10Q Form 4D Molecular Therapeutics 10Q Form Innate Pharma 10Q Form Ventyx Biosciences 10Q Form Journey Medical 10Q Form Puma Biotechnology 10Q Form DiaMedica Therapeutics 10Q Form Spero Therapeutics 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:VTVT) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
